WallStreetZenWallStreetZen

NASDAQ: GRCE
Grace Therapeutics Inc Stock Ownership - Who owns Grace Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Grace Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Opaleye Management Inc10% Owner2026-09-235,318$2.10
$11.17kBuy
Opaleye Management Inc10% Owner2026-09-219,771$2.10
$20.52kBuy
Prashant KohliCEO2026-09-09100,000$2.14
$214.00kBuy
Opaleye Management Inc10% Owner2026-09-095,836$2.09
$12.20kBuy
Opaleye Management Inc10% Owner2026-09-089,393$2.10
$19.70kBuy
Opaleye Management Inc10% Owner2026-08-1411,608$2.09
$24.20kBuy

1 of 1

GRCE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GRCE insiders and whales buy or sell their stock.

GRCE Shareholders

What type of owners hold Grace Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Grace 2018 Irrevocable Trust Rajitha22.29%4,689,547$10.13MInsider
Opaleye Management Inc13.57%2,855,318$6.17MInsider
Adar1 Capital Management LLC4.56%959,571$2.07MInsider
George Kottayil2.35%494,698$1.07MInsider
William A. Haseltine1.58%332,836$718.93kInsider
Vimal Kavuru0.59%124,344$268.58kInsider
Prashant Kohli0.58%121,357$262.13kInsider
John Canan0.48%100,000$216.00kInsider
Amresh Kumar0.32%66,712$144.10kInsider
Janelle Dalvise0.25%52,500$113.40kInsider

1 of 3

GRCE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GRCE0.02%47.02%Net BuyingNet Buying
PDSB0.01%44.36%
MGX0.02%34.76%Net BuyingNet Buying
VERU0.01%99.99%Net BuyingNet Buying
DWTX0.01%75.58%
View Top Biotech Stocks

Grace Therapeutics Stock Ownership FAQ

Who owns Grace Therapeutics?

Grace Therapeutics (NASDAQ: GRCE) is owned by 0.02% institutional shareholders, 47.02% Grace Therapeutics insiders, and 52.96% retail investors. Grace 2018 Irrevocable Trust Rajitha is the largest individual Grace Therapeutics shareholder, owning 4.69M shares representing 22.29% of the company. Grace 2018 Irrevocable Trust Rajitha's Grace Therapeutics shares are currently valued at $9.94M.

If you're new to stock investing, here's how to buy Grace Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.